BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hu X, Li D, Fu Y, Zheng J, Feng Z, Cai J, Wang P. Advances in the Application of Radionuclide-Labeled HER2 Affibody for the Diagnosis and Treatment of Ovarian Cancer. Front Oncol 2022;12:917439. [DOI: 10.3389/fonc.2022.917439] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Hu X, Liang Z, Qi L, Li F, Cai X, Cai J. Radiosynthesis, optimization and pharmacokinetic study of the 99mTc-labeled human epidermal growth factor receptor 2 affibody molecule probe 99mTc-(HE)3ZHER2:V2. Nucl Med Commun 2023. [PMID: 36598155 DOI: 10.1097/MNM.0000000000001660] [Reference Citation Analysis]
2 Du W, Jiang P, Li Q, Wen H, Zheng M, Zhang J, Guo Y, Yang J, Feng W, Ye S, Kamara S, Jiang P, Chen J, Li W, Zhu S, Zhang L. Novel Affibody Molecules Specifically Bind to SARS-CoV-2 Spike Protein and Efficiently Neutralize Delta and Omicron Variants. Microbiol Spectr 2022. [DOI: 10.1128/spectrum.03562-22] [Reference Citation Analysis]
3 Liang Z, Hu X, Hu H, Wang P, Cai J. Novel small 99mTc-labeled affibody molecular probe for PD-L1 receptor imaging. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1017737] [Reference Citation Analysis]